# PD-L1 as a biomarker of response to immune-checkpoint inhibitors

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pd-l1-as-a-biomarker-of-response-to-immune-checkpoint-inhibitors/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Deborah B. Doroshow,Sheena Bhalla,Mary Beth Beasley,Lynette M. Sholl,Keith M. Kerr,Sacha Gnjatic,Ignacio I. Wistuba,David L. Rimm,Ming‐Sound Tsao,Fred R. Hirsch |
| Citations | 1,593 |
| DOI | 10.1038/s41571-021-00473-5 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3128131226 |
| PMID | 33580222 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Lynette M. Sholl](https://scholariq.org/researchers/lynette-m-sholl/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.